Precigen (PGEN)
(Delayed Data from NSDQ)
$1.83 USD
-0.10 (-5.18%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $1.83 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth B Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Precigen, Inc. has a market cap of $569.70M, which represents its share price of $1.93 multiplied by its outstanding shares number of 295.18M. As a small-cap company, PGEN's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
PGEN 1.83 -0.10(-5.18%)
Will PGEN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PGEN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PGEN
Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates
Generation Bio Co. (GBIO) Reports Q4 Loss, Tops Revenue Estimates
PGEN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Precigen, Inc. (PGEN) Just Flashed Golden Cross Signal: Do You Buy?
PGEN Stock Surges More Than 40% in a Week: What's Driving the Rally?
Precigen, Inc. (PGEN) Reports Q3 Loss, Lags Revenue Estimates
Other News for PGEN
Commit To Purchase Precigen At $1, Earn 111.7% Annualized Using Options
Unusually active option classes on open July 30th
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Largest borrow rate increases among liquid names
Largest borrow rate increases among liquid names